Tevogen Bio Holdings Inc. (TVGN) — Cash Flow-to-Debt Ratio
Tevogen Bio Holdings Inc. (TVGN) has a Cash Flow-to-Debt Ratio of -0.19x as of March 2026, meaning its operating cash flow of $-2.73 Million could theoretically repay 0% of its total liabilities ($14.76 Million) in one year. Check Tevogen Bio Holdings Inc. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tevogen Bio Holdings Inc. Cash Flow-to-Debt Ratio (2022–2026)
Historical debt coverage capacity for Tevogen Bio Holdings Inc. across 5 annual periods. Also explore how large is Tevogen Bio Holdings Inc.'s balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Tevogen Bio Holdings Inc. (2022–2026)
Year-by-year debt coverage analysis for Tevogen Bio Holdings Inc.. For market capitalisation and broader financial context, see Tevogen Bio Holdings Inc. (TVGN) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.98x | $-12.33 Million | $12.62 Million | ▲ +17.5% |
| 2025 | -1.18x | $-12.00 Million | $10.14 Million | ▼ -1347.8% |
| 2024 | -0.08x | $-8.17 Million | $99.93 Million | ▲ +60.6% |
| 2023 | -0.21x | $-8.66 Million | $41.69 Million | ▲ +5.0% |
| 2022 | -0.22x | $-5.27 Million | $24.15 Million | — |